Pacific Biosciences of California, Inc. - Common Stock (PACB)

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Biosciences of California, Inc. (“PacBio” or “the Company”) (NASDAQ: PACB) for violations of the securities laws.

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences.

Companies Form Expert Working Group to Introduce Essential Tools for AAV Development and Research Professionals

Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms

Pacific Biosciences Of California, Inc. (NASDAQ: PACB) has caught the attention of the investment community today with its bullish price action. The company’s shares are currently up 16.04% on the day to $11.32.

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – November 11, 2021 – New recommendations for colorectal cancer (CRC) screening by both the US Preventative Services Task Force (USPSTF) and from the US Food and Drug Administration are ensuring benefits realized by all—all by moving up the starting screening age of adults […]